Vivesto

Vivesto Debt

The Debt of Vivesto (VIVE.ST) as of Oct 20, 2026 is 13.00 M SEK. In the previous year, Debt was 8.17 M SEK — a change of 59.16% (higher).

Debt

13.00 MSEK

YoY

59.16%

Last updated:

In 2025, Vivesto's total debt was 13.00 M SEK, a 59.16% change from the 8.17 M SEK total debt recorded in the previous year.

The Vivesto Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2015
139.94 M SEK
Jan 1, 2016
168.73 M SEK
Jan 1, 2017
187.26 M SEK
Jan 1, 2018
139.57 M SEK
Jan 1, 2019
94.17 M SEK
Jan 1, 2021
10.43 M SEK
Jan 1, 2022
8.17 M SEK
Jan 1, 2025
13.00 M SEK
The Vivesto Debt history
YEARDebtYoY
13.00 MSEK+59.16%
8.17 MSEK-21.67%
10.43 MSEK-88.93%
94.17 MSEK-32.53%
139.57 MSEK-25.47%
187.26 MSEK+10.98%
168.73 MSEK+20.57%
139.94 MSEK+30.79%
107.00 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Debt Details

Understanding Vivesto's Debt Structure

Vivesto's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Vivesto's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Vivesto’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Vivesto’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Vivesto stock

Debt of Vivesto is 13.00 M SEK in 2025.

Debt of Vivesto changed from 8.17 M SEK to 13.00 M SEK, representing a 59.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Vivesto since 2006 – with annual values, charts, and detailed analysis.

Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Vivesto historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Vivesto

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Vivesto